NL7304085A - - Google Patents

Info

Publication number
NL7304085A
NL7304085A NL7304085A NL7304085A NL7304085A NL 7304085 A NL7304085 A NL 7304085A NL 7304085 A NL7304085 A NL 7304085A NL 7304085 A NL7304085 A NL 7304085A NL 7304085 A NL7304085 A NL 7304085A
Authority
NL
Netherlands
Application number
NL7304085A
Other versions
NL171360C (nl
NL171360B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7304085A publication Critical patent/NL7304085A/xx
Publication of NL171360B publication Critical patent/NL171360B/xx
Application granted granted Critical
Publication of NL171360C publication Critical patent/NL171360C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NLAANVRAGE7304085,A 1972-03-27 1973-03-23 Werkwijze voor het bereiden van een rifamycinederivaat. NL171360C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2242172 1972-03-27

Publications (3)

Publication Number Publication Date
NL7304085A true NL7304085A (sv) 1973-10-01
NL171360B NL171360B (nl) 1982-10-18
NL171360C NL171360C (nl) 1983-03-16

Family

ID=11196065

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7304085,A NL171360C (nl) 1972-03-27 1973-03-23 Werkwijze voor het bereiden van een rifamycinederivaat.

Country Status (24)

Country Link
US (1) US3865812A (sv)
JP (1) JPS5142120B2 (sv)
AR (3) AR205434A1 (sv)
AT (1) AT322106B (sv)
AU (1) AU467606B2 (sv)
BE (1) BE797344A (sv)
CA (1) CA999858A (sv)
CH (1) CH567511A5 (sv)
CS (1) CS168642B2 (sv)
DD (1) DD104517A5 (sv)
DE (1) DE2314478C3 (sv)
ES (1) ES413043A1 (sv)
FR (1) FR2182906B1 (sv)
GB (1) GB1388652A (sv)
HU (1) HU167316B (sv)
IE (1) IE37817B1 (sv)
IL (1) IL41532A0 (sv)
LU (1) LU67287A1 (sv)
NL (1) NL171360C (sv)
PL (1) PL89269B1 (sv)
RO (1) RO62882A (sv)
SE (1) SE381257B (sv)
SU (1) SU497777A3 (sv)
ZA (1) ZA73939B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1053787B (it) * 1974-10-29 1981-10-10 Pastori A Macrolidi azotati e loro preparazione
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
DE2728869A1 (de) * 1976-06-25 1977-12-29 Antibiotice Iasi Intreprindere Rifamycinen und verfahren zu deren herstellung
US4179439A (en) * 1977-07-01 1979-12-18 Intreprinderea De Antibiotice Iasi Rifamycins and method for their preparation
JPS6025436B2 (ja) * 1977-07-15 1985-06-18 イントレプリンデレア・デ・アンテイビオテイスイアシ 水溶性リフアマイシン
JPS5419997A (en) * 1977-07-15 1979-02-15 Intorepurinderea De Anteibiote 33formylrifamycin sv derivative
DE2918140C2 (de) * 1979-05-05 1985-02-07 Fresenius AG, 6380 Bad Homburg Dialysator
AU536524B2 (en) * 1979-06-28 1984-05-10 Gruppo Lepetit S.P.A. Water soluble hydrozones of 3-formylifamyan
US4447432A (en) * 1981-11-17 1984-05-08 Farmitalia Carlo Erba S.P.A. Azino rifamycins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (sv) * 1964-07-31
CH489521A (fr) * 1964-07-31 1970-04-30 Lepetit Spa Procédé de préparation d'un dérivé de la rifamycine SV

Also Published As

Publication number Publication date
JPS495998A (sv) 1974-01-19
ES413043A1 (es) 1976-01-16
CH567511A5 (sv) 1975-10-15
DD104517A5 (sv) 1974-03-12
DE2314478B2 (de) 1980-04-30
IL41532A0 (en) 1973-04-30
NL171360C (nl) 1983-03-16
LU67287A1 (sv) 1973-07-13
SU497777A3 (ru) 1975-12-30
IE37817B1 (en) 1977-10-26
AU5342973A (en) 1974-09-19
JPS5142120B2 (sv) 1976-11-13
DE2314478A1 (de) 1973-10-04
HU167316B (sv) 1975-09-27
AR199720A1 (es) 1974-09-23
AT322106B (de) 1975-05-12
BE797344A (fr) 1973-07-16
RO62882A (fr) 1977-11-15
AU467606B2 (en) 1975-12-04
SE381257B (sv) 1975-12-01
PL89269B1 (sv) 1976-11-30
FR2182906B1 (sv) 1975-10-31
GB1388652A (en) 1975-03-26
ZA73939B (en) 1973-11-28
AR205434A1 (es) 1976-05-07
NL171360B (nl) 1982-10-18
CS168642B2 (sv) 1976-06-29
CA999858A (en) 1976-11-16
IE37817L (en) 1973-09-27
ATA266074A (de) 1975-06-15
AR203839A1 (es) 1975-10-31
US3865812A (en) 1975-02-11
DE2314478C3 (de) 1981-01-08
FR2182906A1 (sv) 1973-12-14

Similar Documents

Publication Publication Date Title
FR2197269A1 (sv)
FR2208414A5 (sv)
JPS4989494A (sv)
FR2182906B1 (sv)
FR2199611A1 (sv)
JPS49703A (sv)
JPS4952616A (sv)
JPS4910771A (sv)
JPS4929100A (sv)
JPS4875387A (sv)
JPS496502U (sv)
JPS4982905U (sv)
JPS4922784U (sv)
JPS4962255U (sv)
CS152691B1 (sv)
CS165064B1 (sv)
JPS4995075U (sv)
CH577303A5 (sv)
CH606304A5 (sv)
BG20645A1 (sv)
CH578290A5 (sv)
CH559550A5 (sv)
CH559489A5 (sv)
CH812573A4 (sv)
CH608780A5 (sv)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee